Contribution of Sympathetic Nervous System Activity during Administration of Carvedilol in Rats with Dilated Cardiomyopathy
暂无分享,去创建一个
M. Miyazaki | K. Yamaguchi | Kenichi Watanabe | M. Kodama | Y. Aizawa | Meilei Ma | M. Naito | H. Tachikawa | G. Hasegawa | N. Tanabe | J. Wen | Masao Kakemi | Toshihiro Takahashi | Yuichi Abe | Ken Shirai | Yuki Saito | P. Suresh | G. Narasimman | Fadia Ali | M. Soga | Yusuke Nagai | Shinji Sato | Mir I. I. Wahed | Y. Nagai
[1] Kenichi Watanabe,et al. Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy , 2000, British journal of pharmacology.
[2] ICHAEL,et al. THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE , 2000 .
[3] P. Lauriola,et al. Avoidable deaths from vehicle accidents in Modena, Italy , 1998, The Lancet.
[4] M Danhof,et al. Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.
[5] H. Homma,et al. Comparison of the sympathetic nervous system activity between spontaneously hypertensive and Wistar-Kyoto rats to respond to blood pressure reduction. , 1997, Biological & pharmaceutical bulletin.
[6] R. Doughty,et al. Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. , 1997, European heart journal.
[7] Australia.. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease , 1997, The Lancet.
[8] G. Feuerstein,et al. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. , 1995, European heart journal.
[9] A. Koshiro,et al. Pharmacokinetic and pharmacodynamic studies of L-dopa in rats. I. Pharmacokinetic analysis of L-dopa in rat plasma and striatum. , 1994, Biological & pharmaceutical bulletin.
[10] M. Kodama,et al. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. , 1994, Circulation research.
[11] T. Santa,et al. Relation between blood pressure and plasma catecholamine concentration after administration of calcium antagonists to rats. , 1994, Biological & pharmaceutical bulletin.
[12] D. Goldstein,et al. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. , 1994, Journal of chromatography. B, Biomedical applications.
[13] A. Shibata,et al. Alterations of binding characteristics of alpha 1-,beta 1-adrenoceptors and Ca2+ binding sites in the myocardium of spontaneously hypertensive rats (SHR) by chronically administered bunazosin, atenolol, ketanserin and verapamil. , 1993, Biological & pharmaceutical bulletin.
[14] E. Varnauskas,et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. , 1975, British heart journal.